BIOLASE Inc  

(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for biol
1.78
+0.05 (2.83%)
Real-time:   9:48AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.70 - 1.79
52 week 0.65 - 1.98
Open 1.70
Vol / Avg. 4,497.00/61,918.00
Mkt cap 119.51M
P/E     -
Div/yield     -
EPS -0.25
Shares 67.57M
Beta 2.00
Inst. own 42%
Mar 7, 2017
Q4 2016 BIOLASE Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 8, 2016
Q3 2016 BIOLASE Inc Earnings Call
Nov 8, 2016
Q3 2016 BIOLASE Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -23.78% -41.83%
Operating margin -23.80% -41.08%
EBITD margin - -40.78%
Return on average assets -31.30% -39.90%
Return on average equity -75.53% -60.55%
Employees 200 -
CDP Score - -

Address

4 CROMWELL
IRVINE, CA 92618-1816
United States - Map
+1-949-3611200 (Phone)
+1-949-2736677 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Officers and directors

Paul N. Clark Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Harold C. Flynn Jr. President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
David C. Dreyer CPA Chief Financial Officer
Age: 59
Bio & Compensation  - Reuters
Brendan O'Connell Vice President - Finance and Corporate Controller
Age: 38
Bio & Compensation  - Reuters
Holger Arens Vice President, Managing Director of Europe, the Middle East and Africa
Age: 54
Bio & Compensation  - Reuters
Michael Roux Vice President of Marketing
Bio & Compensation  - Reuters
Matthew Wilson Vice President of Human Resources
Bio & Compensation  - Reuters
Samuel B. Low Vice President - Dental and Clinical Affairs, Chief Dental Officer
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 60
Bio & Compensation  - Reuters
Tamar D. Howson Director
Age: 68
Bio & Compensation  - Reuters